首页> 美国卫生研究院文献>Upsala Journal of Medical Sciences >The H1-receptor antagonist cetirizine ameliorates high-fat diet-induced glucose intolerance in male C57BL/6 mice but not diabetes outcome in female non-obese diabetic (NOD) mice
【2h】

The H1-receptor antagonist cetirizine ameliorates high-fat diet-induced glucose intolerance in male C57BL/6 mice but not diabetes outcome in female non-obese diabetic (NOD) mice

机译:H1受体拮抗剂西替利嗪改善雄性C57BL / 6小鼠高脂饮食诱导的葡萄糖耐受不良但改善雌性非肥胖糖尿病(NOD)小鼠的糖尿病结局

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background It has been proposed that the histamine 1-receptor (H1-receptor) not only promotes allergic reactions, but also modulates innate immunity and autoimmune reactions. In line with this, we have recently reported that the H1-receptor antagonist cetirizine partially counteracts cytokine-induced beta-cell signaling and destruction. Therefore, the aim of this study was to determine whether cetirizine affects diabetes in NOD mice, a model for human type 1 diabetes, and glucose intolerance in high-fat diet C57BL/6 mice, a model for human glucose intolerance.
机译:背景技术已经提出组胺1-受体(H1-受体)不仅促进过敏反应,而且调节先天免疫和自身免疫反应。与此相符,我们最近报道了H1受体拮抗剂西替利嗪部分抵消了细胞因子诱导的β细胞信号转导和破坏。因此,本研究的目的是确定西替利嗪是否会影响人1型糖尿病模型NOD小鼠的糖尿病以及高脂饮食C57BL / 6小鼠人葡萄糖耐受性模型中的葡萄糖耐受性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号